Official BRACELET-1 Trial Shows Pelareorep Combined with Paclitaxel Holds Promise in HR+ HER2- Metastatic Breast Cancer
In a groundbreaking development within the field of metastatic breast cancer treatment, the results of the BRACELET-01 (PrECOG 0113) trial ...


















![PD-L1 targeting molecular imaging in head and neck carcinoma: A head-to-head comparison of [18F]AlF-NOTA-PCP2 PET and [18F]FDG PET/CT.](https://bioengineer.org/wp-content/uploads/2025/06/SNMMI-Image-of-the-Year-Novel-Immuno-PET-Tracer-Outperforms-FDG-350x250.jpeg)
